curasan AG (CUR):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:curasan AG (CUR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9792
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
curasan AG (curasan) develops, manufactures and commercializes medical devices in the field of regenerative medicine. The company offers a wide range of synthetic bone substitutes, dental and bone regeneration material products. It offers these products to orthopedic and spinal surgeons, oral and maxillofacial surgeons, and periodontists and dental implantologists in the fields of bone and tissue regeneration, tissue engineering, and wound healing for dental, spinal and orthopedic applications. The company has a research and development, and manufacturing facility in Frankfurt, Germany. The company offers its products through a network of distributors in the Americas, Europe, the Middle East and Asia. curasan is headquartered in Kleinostheim, Germany.

curasan AG (CUR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
curasan AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
curasan AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
curasan AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
curasan AG, Medical Devices Deals, 2012 to YTD 2018 8
curasan AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
curasan AG, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Curasan Enters into Distribution Agreement with implantcast 10
Equity Offering 11
Curasan to Raise USD6 Million in Private Placement of Shares 11
Curasan Raises USD1.2 Million in Private Placement of Shares 12
curasan to Raise USD4.6 Million in Rights Issue of Shares 13
curasan AG – Key Competitors 14
curasan AG – Key Employees 15
curasan AG – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Financial Announcements 17
May 24, 2018: curasan concludes first quarter in line with annual guidance 17
Apr 26, 2018: Curasan Reports Full Year 2017 Financial Results 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
curasan AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2
curasan AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
curasan AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
curasan AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
curasan AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
curasan AG, Medical Devices Deals, 2012 to YTD 2018 8
curasan AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Curasan Enters into Distribution Agreement with implantcast 10
Curasan to Raise USD6 Million in Private Placement of Shares 11
Curasan Raises USD1.2 Million in Private Placement of Shares 12
curasan to Raise USD4.6 Million in Rights Issue of Shares 13
curasan AG, Key Competitors 14
curasan AG, Key Employees 15
curasan AG, Subsidiaries 16

List of Figures
curasan AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
curasan AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
curasan AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
curasan AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
curasan AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
curasan AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
curasan AG, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[curasan AG (CUR):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Gelsenwasser AG (WWG):企業の財務・戦略的SWOT分析
    Summary Gelsenwasser AG (Gelsenwasser) is a utility company that supplies natural gas and fresh water. The company distributes electricity, water, gas, and heat for residents in Germany. Its services include online service, repair services, energy performance certifications, debugging and installati …
  • Gulf Keystone Petroleum Ltd (GKP):企業の財務・戦略的SWOT分析
    Summary Gulf Keystone Petroleum Ltd (Gulf Keystone) is an oil and gas company that offers operation and production of oil and natural gas reserves. The company operates working interests in the Republic of Algeria and the Kurdistan Region of Northern Iraq. Its Kurdistan Region of Iraq operates produ …
  • Ryerson Holding Corp:企業の戦略・SWOT・財務情報
    Ryerson Holding Corp - Strategy, SWOT and Corporate Finance Report Summary Ryerson Holding Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Trammo Inc.:戦略・SWOT・企業財務分析
    Trammo Inc. - Strategy, SWOT and Corporate Finance Report Summary Trammo Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • NanoCarrier Co Ltd (4571):企業の財務・戦略的SWOT分析
    Summary NanoCarrier Co Ltd (NanoCarrier) is a drug development company that develops and produces pharmaceuticals using micellar nanoparticles technology. The company’s pipeline products include NC-6004, NC-4016, NC-6300, VB-111, NC-6201 and NK105. It offers siRNA micelle, protein micelle, DACH-plat …
  • Premier Biomedical Inc (BIEI):製薬・医療:M&Aディール及び事業提携情報
    Summary Premier Biomedical Inc (Premier Biomedical) is a drug development company that develops medications for debilitating and fatal illnesses. The company offers Feldetrex, a drug candidate used for the treatment of multiple sclerosis, fibromyalgia, blood sepsis and viremia, and cancer. It develo …
  • Constellation Pharmaceuticals Inc (CNST):企業の財務・戦略的SWOT分析
    Constellation Pharmaceuticals Inc (CNST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Fluidigm Corp (FLDM)-医療機器分野:企業M&A・提携分析
    Summary Fluidigm Corp (Fluidigm) formerly known as Mycometrix Corporation, is a biotechnology company which manufactures life-science tools and creates technologies based on microfluidics and mass cytometry. The company’s products systems include biomark HD system, access array system, C1 system, ca …
  • Total Gabon SA (EC):企業の財務・戦略的SWOT分析
    Summary Total Gabon SA (Total Gabon), formerly Elf Gabon SA, a subsidiary of Total SA, is an oil and gas company that provides oil exploration and development services. The company explores and extracts hydrocarbon resources. It provides activities such as mining and exploration, production, redevel …
  • Natera Inc (NTRA):製薬・医療:M&Aディール及び事業提携情報
    Summary Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as panorama prenatal testing, pre-implantation genetic testing, miscarriage testing, g …
  • The Cooper Companies, Inc.:企業の戦略・SWOT・財務情報
    The Cooper Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Cooper Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Citizens Electric Corporation:企業の発電所・SWOT分析2018
    Citizens Electric Corporation - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Lunaphore Technologies SA:医療機器:M&Aディール及び事業提携情報
    Summary Lunaphore Technologies SA (Lunaphore) is a medical device company that develops tissue processing solutions for inmmunohistochemistry. The company builds tumor analysis and classification platforms based on a microfluidic technologies. It offers FFeX, a fast fluidic exchange technology that …
  • F-Secure Oyj (FSC1V):企業の財務・戦略的SWOT分析
    F-Secure Oyj (FSC1V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Alder Biopharmaceuticals Inc (ALDR):製薬・医療:M&Aディール及び事業提携情報
    Summary Alder Biopharmaceuticals Inc (Alder) is a biopharmaceutical company which develops, produces and markets monoclonal antibody therapeutics for the treatment of migraine, Cushing’s disease and autoimmune and inflammatory diseases. The company uses technologies such as the antibody selection sy …
  • Seoul National University Hospital:製薬・医療:M&Aディール及び事業提携情報
    Summary Seoul National University Hospital (SNUH) is a healthcare service provider. It operates as the representative medical center of Korea. The hospital focuses on raising the standards of nation’s healthcare system, medical education, research and patient care. It offers services such as outpati …
  • Kimball Electronics Inc (KE):企業の財務・戦略的SWOT分析
    Kimball Electronics Inc (KE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Alafair Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Alafair Biosciences Inc (Alafair Biosciences) is a medical device company that develops and commercialize surgical products for soft tissue repair and protection applications. The company develops products based on a non-cell adhesive hydrogel technology to protect and manage advanced wound …
  • Paranta Biosciences Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Paranta Biosciences Ltd (Paranta Biosciences) is a biopharmaceutical company that develops bio-therapeutics for the treatment of inflammatory and fibrotic diseases. The company develops product candidate PB01, a recombinant human follistatin-288 used for the treatment of cystic fibrosis lung …
  • Procaps SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Procaps SAS (Procaps) is a manufacturing and commercializing company that provides pharmaceutical forms. The company provides softigel products such as RX products, OTC products, natural products, omega 3 fish oils, gummies and veterinary products, among others. Its hospitalaria unit offers …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆